Dose dependent absorption and linear disposition of cyclosporin A in rat

The pharmacokinetics of cyclosporin A (CyA) were investigated in the rat following intravenous doses of 1·7, 3·3, and 6·4 mg kg−1 and oral doses of 3·1, 6·8, and 12·9 mg kg−1. The blood concentration‐time profile after intravenous administration was adequately described by a two‐compartment model when all data were simultaneously analysed using NONMEM. The disposition pharmacokinetics were linear over the dose range studied; the average total blood clearance was 0·191 g−1 kg−1. The absorption process could not be adequately described by either a first‐ or a zero‐order input. Therefore, a flexible, staircase input model was used and found to be superior to the standard models. The shape of this model was biphasic, with a higher initial input rate than expected from first‐order absorption. The duration of this first phase increased with dose. The extent of absorption was also dose dependent. Bioavailability was higher at higher doses; the values were 45%, 67% and 76% for the three ascending dose levels. These results strongly indicate a saturable first‐pass effect. Since the extraction of CyA in the liver is only 6%, the marked increase in bioavailability of CyA is most likely to be the result of saturated gut wall metabolism.

[1]  S L Beal,et al.  Population pharmacokinetic data and parameter estimation based on their first two statistical moments. , 1984, Drug metabolism reviews.

[2]  M. Rowland,et al.  Pharmacokinetics of cyclosporin: influence of rate of constant intravenous infusion in renal transplant patients. , 1987, British journal of clinical pharmacology.

[3]  D. Back,et al.  Cyclosporin metabolism by the gastrointestinal mucosa. , 1991, British journal of clinical pharmacology.

[4]  R. Venkataramanan,et al.  Clinical Pharmacokinetics of Cyclosporin , 1986, Clinical pharmacokinetics.

[5]  R. Didlake,et al.  Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat. , 1988, Transplantation proceedings.

[6]  A. Thomson,et al.  Cyclosporin: use outside transplantation. , 1991, BMJ.

[7]  M. Lemaire,et al.  Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats. , 1983, Biopharmaceutics & drug disposition.

[8]  T. Starzl,et al.  CYCLOSPORINE METABOLISM AND PHARMACOKINETICS FOLLOWING INTRAVENOUS AND ORAL ADMINISTRATION IN THE DOG1 , 1986, Transplantation.

[9]  R. Venkataramanan,et al.  Cyclosporine Concentration Determinations for Monitoring and Pharmacokinetic Studies , 1986, Journal of clinical pharmacology.

[10]  B. Langer,et al.  PHARMACOKINETIC PROFILES OF CYCLOSPORINE IN RATS: INFLUENCE OF ROUTE OF ADMINISTRATION AND DOSAGE , 1985, Transplantation.

[11]  L. Demers,et al.  Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring. , 1987, Clinical Chemistry.

[12]  N Aoyagi,et al.  Application of the NONMEM method to evaluation of the bioavailability of drug products. , 1990, Journal of pharmaceutical sciences.

[13]  M. Lemaire,et al.  Apparent dose-dependent oral absorption of cyclosporin A in rats. , 1984, Biopharmaceutics & drug disposition.